Skip to content

Hypertension Patients on Drug Medication Adherence and Rational Medication Use

The Effect of Education and Telephone Counseling Given to Hypertension Patients on Drug Medıcation Adherence and Rational Medication Use: Single-Blind Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05060575
Enrollment
84
Registered
2021-09-29
Start date
2021-10-01
Completion date
2022-06-01
Last updated
2022-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Patients

Keywords

Hypertension, Tele nursing, Education, Rational medication use, Drug medication adherence, Nursing

Brief summary

This research will be conducted to determine the effects of education and telephone counseling given to hypertension patients on drug treatment compliance and rational drug use.

Detailed description

This research will be conducted to determine the effects of education and telephone counseling given to hypertension patients on drug treatment compliance and rational drug use. Research Hypotheses H0: Education and telephone counseling given to hypertension patients do not affect drug treatment compliance. H1: Education and telephone counseling given to hypertension patients increase drug treatment compliance. H0: Education and telephone counseling given to hypertension patients do not affect rational drug use. H1: Education and telephone counseling given to hypertension patients increase rational drug use. This study was planned as a single-blind randomized controlled experimental study.

Interventions

OTHEREducation and Telephone Counceling

Drug use and rational drug use training will be given to hypertension patients in the experimental group. The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.

Sponsors

Ordu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \- Diagnosed with hypertension, * Hypertension disease duration of at least 6 months, * Using at least one drug due to hypertension, * 18 years old and over * Literate, * Living in the town centre, * Owns a phone * Open to communication and cooperation, * Patients willing to participate in the study will be included in the study.

Exclusion criteria

* Having a psychiatric illness * Hearing loss, * Can't understand or speak Turkish and * Patients who do not wish to continue the study will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Adherence to Medication Self-Efficacy Scale12 weeksThe scale consists of 13 items and determines the self-efficacy/confidence level of adherence to drug treatments of individuals with hypertension. The scale is evaluated by scoring from 1 to 4 in each question. The minimum score that can be obtained from the scale is 13, and the maximum score is 52. The increase in the scale score indicates that the compliance of individuals to antihypertensive drug treatment increases positively.
Rational Drug Use Scale12 weeksThe scale has 36 items and is a triple Likert type. Behavioral beliefs (items 1-9), Control beliefs (items 10-16), Attitude (items 17-21), Subjective norm (items 22-23), Intention (items 24-28), and Knowledge It has 6 sub-dimensions (items between 29 and 36). Scoring of scale items was never (0), sometimes (1), and always (2) for positive items; negative items (items 13, 14, 17, 18, 19, 20, 21, and 24) are calculated as never (2), sometimes (1), and always (0). The scores that can be obtained from the scale range from 0 to 72. As the score obtained from the scale increases, the level of rational drug use increases.

Secondary

MeasureTime frameDescription
Diastolic/Systolic blood pressure12 weeksSystolic and Diastolic blood pressure will be measured.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026